Predictive ability of reconstructed human epidermis equivalents for the assessment of skin irritation of cosmetics

Toxicology in Vitro

Volumn 16, Issue 5, 2002, Pages 557-572

  Faller, C ^a   Bracher, M ^a   Dami, N ^b   Roguet, R ^b  

^a Wella Cosmital SA   (Switzerland)

^b L ORÉAL RECHERCHE   (France)

Author keywords

Alternative methods; EpiDerm ; EPISKIN ; In vitro testing; In vivo in vitro comparison (concordance); Reconstructed human epidermis models (equivalents); Skin irritation

Indexed keywords

COSMETIC; INTERLEUKIN 1ALPHA; LACTATE DEHYDROGENASE;

ARTICLE; CELL VIABILITY; CLASSIFICATION; CYTOKINE RELEASE; DRY SKIN; ENZYME RELEASE; EPIDERMIS; ERYTHEMA; IN VIVO STUDY; LINEAR REGRESSION ANALYSIS; MEASUREMENT; MEDICAL ASSESSMENT; PREDICTION; SKIN IRRITATION; SKIN MANIFESTATION; SKIN WATER LOSS; TOXICITY TESTING;

EID: 0036801025     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2333(02)00053-X     Document Type: Article

References (33)

1. Bell E., Ehrlich H.P., Buttle D.J., Nakatsuji T. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science. 211:1981;1051-1054.
2. Bell E., Parenteau N., Gay R., Nolte C., Kemp P., Bilbo P., Ekstein B., Johnson E. The living skin equivalent. its manufacture, its organotypic properties and its responses to irritants Toxicology in Vitro. 5:1991;591-596.
3. Boelsma E., Gibbs S., Faller C., Ponec M. Characterization and comparison of reconstructed skin models. morphological and immunohistochemical evaluation Acta Dermato-Venereologica. 80:2000;82-88.
4. Botham P.A., Earl L.K., Fentem J.H., Roguet R., van de Sandt J.J.M. Alternative methods for skin irritation testing. the current status ECVAM Skin Irritation Task Force report 1 ATLA. 26:1998;195-211.
5. Cannon C.L., Neal P.J., Southee J.A., Kubilus J., Klausner M. New epidermal model for dermal irritancy testing. Toxicology in Vitro 8 (4). 1994;889-891.
6. de Brugerolle de Fraissinette A., Picarles V., Chibout S., Kolopp M., Medina J., Burtin P., Ebelin M.E., Osborne S., Mayer F.K., Spake A., Rosdy M., De Wever B., Ettlin R.A., Cordier A. Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles. Cell Biology and Toxicology. 15:1999;121-135.
7. 2® - an in vitro human skin model. the correlation between in vivo and in vitro testing of surfactants Experimental Dermatology. 7:1998;18-26.
8. Faller C., Bracher M. Reconstructed skin kits: Reproducibility of cutaneous irritancy testing. Skin Pharmacology and Applied Skin Physiology (in press).
9. Fentem J.H., Briggs D., Chesné C., Elliott G.R., Harbell J.W., Heylings J.R., Portes P., Roguet R., van de Sandt J.J.M., Botham P.A. A prevalidation study on in vitro tests for acute skin irritation. results and evaluation by the Management Team Toxicology in Vitro. 15:2001;57-93.
10. Gay R., Swiderek M., Nelson D., Ernesti A. The living skin equivalent as a model in vitro for ranking the toxic potential of dermal irritants. Toxicology in Vitro 6 (4). 1992;303-315.
11. Höskuldsson A. Prediction Methods in Science and Technology. 1996;Thor Publishing, Copenhagen, Denmark.
12. Jackson J.E. A User's Guide to Principal Components. 1991;John Wiley, New York.
13. Limat A., Hunziker T. Epidermal equivalents generated from cultured outer root sheath cells. In Vitro Toxicology 10 (1). 1997;33-38.
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival. application to proliferation and cytoxicity assays Journal of Immunological Methods. 65:1983;55-63.
15. Müller-Decker K., Furstenberger G., Marks F. Keratinocyte-derived pro-inflammatory key mediators and cell viability as in vitro parameters of irritancy. a possible alternative to the Draize skin irritation test Toxicology and Applied Pharmacology. 127:1994;99-108.
16. Noser F.K., Limat A. Organotypic culture of outer root sheath cells from human hair follicles using a new culture device. In Vitro Cellular and Developmental Biology 23 (8). 1987;541-545.
17. Osborne R., Perkins M.A. In vitro skin irritation testing with human skin cultures. Toxicology in Vitro. 5:1991;563-567.
18. Ponec M. The use of in vitro skin recombinants to evaluate cutaneous toxicity. Rougier A., Goldberg A., Maibach H.I. In Vitro Skin Toxicology, Irritation, Phototoxicity, Sensibilization. 1994;107-116 Mary Ann Liebert, New York.
19. Ponec, M., Boelsma E., Gibbs S, Mommaas M. Characterization of reconstructed skin models. Skin Pharmacology and Applied Skin Physiology (in press).
20. Ponec M., Boelsma E., Weerheim A., Mulder A., Bouwstra J., Mommaas M. Lipid and ultrastructural characterization of reconstructed skin models. International Journal of Pharmaceutics. 203:2000;211-225.
21. Ponec M., Kempenaar J. Use of human skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritants. Skin Pharmacology. 8:1995;49-59.
22. Prunieras M. Skin and epidermal equivalents: a review. Rougier A., Goldberg A., Maibach H.I. In Vitro Skin Toxicology, Irritation, Phototoxicity, Sensibilization. 1994;97-105 Mary Ann Liebert, New York.
23. Prunieras M., Regnier M., Schloetterer M. A new method to culture human epidermal cells on allogeneic or xenogeneic dermis. preparation of recombined grafts Annales de Chirurgie Plastique. 24:1979;357-362.
24. Roguet R. Use of skin cell cultures for in vitro assessment of corrosion and cutaneous irritancy. Cell Biology and Toxicology. 15:1999;63-75.
25. Roguet R., Cohen C., Dossou K.G., Rougier A. Episkin™, a reconstituted human epidermis for assessing in vitro the irritancy of topically applied compounds. Toxicology in Vitro 8 (2). 1994;283-291.
26. Roguet R., Cohen C., Robles C., Courtellemont P., Tolle M., Guillot J.P., Pouradier Duteil X. An interlaboratory study of the reproducibility and relevance of Episkin™, a reconstructed human epidermis, in the assessment of cosmetics irritancy. Toxicology in Vitro. 12:1998;295-304.
27. Roguet R., Faller C., Dreher F., Lotte C., Harris I., Bracher M., Pollet D., Pfannenbecker U., Dami N., Ponec M., 2001. Evaluation of reconstructed human epidermis kits for the in vitro assessment of cosmetic safety. Proceedings - 2001 IFSCC Conference, Stockholm, pp. 103-124.
28. Roguet R., Régnier M., Cohen C., Dossou K.G., Rougier A. The use of in vitro reconstituted human skin in dermotoxicity testing. Toxicology in Vitro 8 (4). 1994;635-639.
29. Rosdy M., Clauss L.C. Terminal epidermal differenciation of human keratinocytes grown in chemically defined medium on inert filter substrates at the air-liquid interface. Journal of Investigative Dermatology. 95:1990;409-414.
30. Slivka S.R., Zeigler F. Use of an in vitro skin model for determining epidermal and dermal contributions to irritant responses. Journal of Toxicology - Cutaneous and Ocular Toxicology 12 (1). 1993;49-57.
31. Tinois E., Tiollier J., Gaucherand M., Dumas H., Tardy M., Thivolet J. In vitro and post-transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute. Experimental Cell Research. 193:1991;310-319.
32. van de Sandt J., Roguet R., Cohen C., Esdaile D., Ponec M., Corsini E., Barker C., Fusenig N., Liebsch M., Benford D., de Brugerolle de Fraissinette A., Fartasch M. The use of human keratinocytes and human skin models for predicting skin irritation. The report and recommendations of ECVAM workshop 38. ATLA. 27:1999;723-743.
33. Wahlen E., Donnelly T.A., Naughton G., Rheins L.A. The development of three-dimensional in vitro human tissue models. Human and Experimental Toxicology. 13:1994;853-859.